Probing the fetal genome: progress in non-invasive prenatal diagnosis.
Progress in our understanding of the molecular basis of heritable diseases, through identification of specific mutations, has provided a foundation for the development of DNA-based prenatal diagnosis. Genetic analysis of fetal DNA is now routinely performed from chorionic villus samples obtained as early as the tenth week of gestation or by amniocentesis from week 15 onwards. However, both of these approaches involve invasive procedures with increased risk of fetal loss. To avoid such complications, attempts have been made to develop non-invasive tests through the identification, characterization and isolation of fetal cells or free fetal DNA from the maternal circulation. Recently, progress has been made towards the development of novel strategies that are expected to provide non-invasive means for early prenatal diagnosis in pregnancy.
Uitto
Jouni
J
Department of Dermatology and Cutaneous Biology, Jefferson Medical College, and Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. jouni.uitto@jefferson.edu
Pfendner
Ellen
E
Jackson
Laird G
LG
D004247:DNA / Q000097:blood / Q000302:isolation & purification*; D005260:Female; D005333:Fetus / Q000166:cytology; D015894:Genome, Human; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods*; D012313:RNA / Q000097:blood / Q000302:isolation & purification; D016615:Telomere / Q000235:genetics; D014327:Trophoblasts
D012313:RNA; D004247:DNA